GPT Healthcare Limited announced its financial results for the quarter ended September 30, 2025 (Q2 FY26), reporting a steady revenue increase but lower profitability compared to the same period last year.
The company’s revenue from operations grew 12.5% year-on-year to Rs 118.9 crore, up from Rs 105.7 crore in Q2 FY25. Total income for the quarter stood at Rs 120.2 crore, reflecting consistent growth driven by improved hospital occupancy and higher average revenue per bed.
However, profit after tax (PAT) declined to Rs 10.6 crore, compared to Rs 14.8 crore in the corresponding quarter last year, primarily due to higher expenses and depreciation costs.
EBITDA for the quarter stood at Rs 21.1 crore, compared to Rs 24.9 crore in Q2 FY25, with an EBITDA margin of around 17.7%, impacted by rising employee and operating costs.
For the half-year ended September 30, 2025, GPT Healthcare reported a net profit of Rs 18.3 crore on total income of Rs 228.9 crore, maintaining a healthy performance amid rising cost pressures.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
